Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Edmond Nicolae Barcan
Observed name:
Edmond Barcan
Institutions:
University of Medicine and Pharmacy of Craiova,
University of Craiova
Observed institutions:
Carol Davila University of Medicine and Pharmacy,
Clinical Emergency Hospital Bucharest,
University of Medicine and Pharmacy of Craiova,
University of Craiova
ORCID:
0000-0002-2744-5638
Observed ORCID:
0000-0002-2744-5638
OpenAlex ID:
A5007738003
The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
2021
·
Oana-Stefana Purcaru
, Stefan-Alexandru Artene
, et al.
·
International Journal of Molecular Sciences
·
25
PDF
Current Research Trends in Glioblastoma: Focus on Receptor Tyrosine Kinases
2025
·
Edmond Nicolae Barcan
, Carmen Duta
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Digital-Focused Approaches in Cancer Patients’ Management in the Post-COVID Era: Challenges and Solutions
2024
·
Ilona Georgescu
, Anica Dricu
, et al.
·
Applied Sciences
·
7
PDF
β-arrestin 1 transfection induced cell death in high grade glioma in vitro
2020
·
Catalin Folcuti
, Cristina Horescu
, et al.
·
Journal of Immunoassay and Immunochemistry
·
2
Improving the Response of High-Grade Glioma (HGG) Cells to Temozolomide Treatment Through Combination With Imatinib
2025
·
Georgiana-Adeline Staicu
, Alexandra Costachi
, et al.
·
Cureus
·
1
PDF
Biobanks. Associated Risks and Benefits
2021
·
Edmond Barcan
, Stefan-Alexandru Artene
, et al.
·
Medico Oncology
·
1
PDF
Evaluation of Single and Combined Temozolomide and Doxorubicin Treatment Responses in Low- and High-Grade Glioma In Vitro
2024
·
Georgiana Adeline Staicu
, Ligia G Tataranu
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
7
Citation count:
47
H-index:
3
I10-index:
2
Year
Topic
Type